Scholarly article on 3,4,16,17-Tetraphenylheptacyclo6,10.02,5.014,28.015,18.023,27>-octacosa-1(26),6,8,10(28),11,13,19,21,23(27),24-decaen 32659-60-2 from Journal of the American Chemical Society p. 725 - 731

DOI: 10.1021/ja00732a029

Source and publish data:

Journal of the American Chemical Society p. 725 - 731 (1971)

Update date:2022-07-29

Topics:

Authors:

Meinwald,J.

Young,J.W.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00732a029

Full text of DOI:10.1021/ja00732a029

Products guided by the article

Product name:3,4,16,17-Tetraphenylheptacyclo<17.7.1.1^6,10.0^2,5.0^14,28.0^15,18.0^23,27>-octacosa-1(26),6,8,10(28),11,13,19,21,23(27),24-decaen

Cas No:32659-60-2

R&D Labs maybe for 32659-60-2

Shanghai Run-Biotech Co., Ltd.

website:http://www.run-biotech.com

Contact:+86-21-31576854/57171705 / 57171706

Address:second floor, building 3, No.999, jiangyue Road, minghang District, Shanghai, China
ShanDong XinDa Chemical CO.,LTD(expird)

Contact:086-0311-87580543

Address:No.168, High Technology Development Zone Jinan Shandong China
Jurong Huaheng Natural Biological Products Factory

website:http://www.risebiochem.com

Contact:+86-13921007726

Address:Chuncheng town,Jurong city,Jiangsu province,China
Chengdu Biopurify Phytochemicals Ltd.

website:http://www.phytopurify.com

Contact:+86-28-82633397

Address:2F,No.11 Building,No.388 Rongtaidadao CNSTP,Wenjiang Zone,Chengdu,Sichuan, China
KangZhiYuan Pharmaceutical Company Limited

Contact:(Sabrina)86-20-85273232

Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China

Relevant to this article

Total synthesis of (+)-crocacin C

Doi:10.1016/S0040-4020(01)00940-1
(2001)
New synthetic strategy for chiral 2-oxazolidinones derivatives via rhodium-catalyzed asymmetric hydrogenation

Doi:10.1016/j.tetlet.2015.12.105
(2016)
Synthesis of analogs of the ergot alkaloids

Doi:10.1002/jhet.5570370614
(2000)
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutan

Doi:10.1021/acs.jmedchem.7b00840
(2017)
Generation and amphoteric redox properties of novel neutral radicals with the TTF-TCNQ hybrid structure

Doi:10.3987/COM-00-S(I)60
(2001)
Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor

Doi:10.1016/S0960-894X(00)00168-2
(2000)

Article Doi

DOI: 10.1021/ja00732a029